Average Co-Inventor Count = 3.88
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Ocular Therapeutix, Inc. (11 from 18 patents)
11 patents:
1. 12357565 - Ocular implant containing a tyrosine kinase inhibitor
2. 12329853 - Compositions and methods for treating ocular diseases
3. 12161753 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and an active agent
4. 12144889 - Methods of treating allergic conjunctivitis
5. 12109302 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
6. 11779536 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
7. 11622935 - Methods of treating ocular diseases using polyalkylene glycol intracameral implants with polyactide travoprost particles
8. 11534396 - Methods of treatment with an ocular implant containing a tyrosine kinase inhibitor
9. 11439592 - Ocular implant containing a tyrosine kinase inhibitor
10. 11331267 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine
11. 11291627 - Sustained release biodegradable intracanalicular inserts comprising a hydrogel and cyclosporine